Gracell Biotechnologies
亘喜生物
Gracell Biotechnologies
Biotech/Healthcare
Gracell Biotechnologies is an innovative biopharmaceutical company focused on developing next-generation cell therapies. It aims to develop high-quality, low-cost CAR-T cell therapies that address technical challenges in cell and gene therapy, including complex manufacturing, the lack of…
Latest round: Post-IPO (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.